Glaxosmithkline Plc on Wednesday posted an 74 percent rise in profit after tax for the third quarter of 2011, a result at the bottom of analysts' expectations for Europe's biggest pharmaceutical company.
Glaxosmithkline posts increase in third quarter earnings sales.